The global single-use bioprocessing market is undergoing rapid transformation as biopharmaceutical manufacturers increasingly adopt flexible, scalable, and cost-efficient manufacturing technologies. Single-use systems are gaining traction across biologics, vaccines, monoclonal antibodies, recombinant proteins, and advanced therapies because they can reduce cleaning requirements, shorten facility setup times, and lower the risk of cross-contamination compared with conventional stainless-steel systems.

The global single-use bioprocessing market was valued at USD 37.8 billion in 2025 and is projected to reach USD 41.1 billion in 2026. According to Grand View Research, the market is expected to reach USD 80.4 billion by 2033, expanding at a CAGR of 10.1% from 2026 to 2033. North America accounted for the largest regional revenue share of 34.7% in 2025, supported by its established biopharmaceutical manufacturing ecosystem, extensive R&D activity, and growing adoption of flexible production technologies.

Download a free sample copy of the Single-use Bioprocessing Market report to understand detailed coverage and inclusions in the final report

Key Market Segments

The market's structural landscape demonstrates strong demand across disposable components, bioprocessing workflows, end users, and major geographic markets.

• By Product: The simple & peripheral elements segment dominated the market with a 48.9% revenue share in 2025. Tubing, filters, connectors, transfer systems, bags, sampling systems, probes, and sensors are widely used across single-use manufacturing processes. The segment is also expected to register the fastest CAGR over the forecast period as manufacturers continue introducing customized and compatible components.

• By Workflow: Upstream bioprocessing accounted for the largest revenue share of 58.4% in 2025. Increasing adoption of advanced cell-culture technologies, micro-bioreactors, automated sampling, and media optimization is supporting the segment.

• By End Use: Biopharmaceutical manufacturers represented the leading end-use segment, accounting for a 57.9% revenue share in 2025. The commercial success of biologics and growing outsourcing of bioprocessing activities are supporting demand for single-use systems across production environments.

• By Region: North America led the global market with a 34.7% revenue share in 2025, while Asia Pacific is projected to be the fastest-growing regional market from 2026 to 2033. The U.S. held the largest country-level market share in 2025.

Major Drivers & Emerging Trends

Rising Biologics and Advanced Therapy Production

The growing development of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies is creating substantial demand for flexible manufacturing systems. Single-use technologies are particularly suitable for biologics because they support rapid setup, reduce cleaning and sterilization requirements, and help minimize cross-contamination risks.

The expansion of personalized medicine is also increasing demand for smaller and more flexible production batches. Modular manufacturing facilities equipped with disposable technologies can enable manufacturers to switch between products more efficiently.

Lower Capital and Operating Requirements

One of the key advantages of single-use systems is their potential to reduce capital investment compared with conventional stainless-steel infrastructure. Manufacturers can avoid or reduce the need for extensive cleaning systems, sterilization infrastructure, and fixed equipment.

These advantages are particularly relevant for emerging biopharmaceutical companies and contract manufacturing organizations seeking flexible capacity without committing to large permanent facilities. Grand View Research identifies reductions in operating and production costs and faster product-development timelines as important factors supporting market growth.

Growth of CDMOs and Outsourced Manufacturing

Increasing outsourcing within the biopharmaceutical industry is strengthening demand for single-use technologies. Contract development and manufacturing organizations require flexible systems capable of handling multiple products and clients without lengthy equipment changeover periods.

Single-use platforms allow CDMOs to adapt production environments more efficiently, supporting their ability to manage changing product portfolios and different manufacturing requirements.

Digitization and Process Automation

The integration of sensors, automation, and advanced monitoring technologies is creating new opportunities for single-use bioprocessing. Disposable probes and sensors can provide real-time information on important process parameters, while automated systems can improve consistency and reduce manual intervention.

As biopharmaceutical manufacturers increasingly prioritize process efficiency and data-driven production, the integration of single-use equipment with digital manufacturing platforms is expected to become more important.

Regional Insights

• North America – Market Leader: North America accounted for 34.7% of global revenue in 2025. The region benefits from an established pharmaceutical and biomanufacturing industry, extensive R&D activity, strong vaccine-production capabilities, and growing adoption of disposable systems. The U.S. held the largest share within the region.

• Asia Pacific – Fastest-Growing Region: Asia Pacific is projected to register the highest CAGR from 2026 to 2033. Increasing investment in biopharmaceutical manufacturing, biosimilars, biologics, and advanced therapies is supporting regional adoption. China and India are becoming increasingly important manufacturing and development centers.

• Europe – Established Bioprocessing Market: Europe has a strong pharmaceutical and biotechnology ecosystem, creating consistent demand for single-use equipment across research, clinical development, and commercial manufacturing.

• Latin America – Emerging Manufacturing Opportunities: Growing investments in pharmaceutical production and healthcare infrastructure are creating opportunities for flexible bioprocessing technologies, particularly where manufacturers seek scalable production capabilities.

• Middle East & Africa – Developing Biomanufacturing Base: Increasing healthcare investments and efforts to strengthen local pharmaceutical manufacturing are gradually creating opportunities for single-use systems.

Looking for more specific insights? Customize this report to suite your business needs

Technology and Product Innovation

Innovation remains an important component of the single-use bioprocessing industry. Manufacturers are developing improved polymer materials, customized assemblies, high-performance sensors, and larger-capacity disposable equipment to address evolving requirements.

Single-use bioreactors are available across a broad range of working volumes, allowing manufacturers to apply disposable technologies from early-stage process development through larger-scale biologics production. This scalability is helping expand the applicability of single-use systems beyond laboratory and clinical environments.

The industry is also moving toward integrated single-use workflows in which bags, tubing, sensors, filtration systems, pumps, and bioreactors can operate as connected systems. This approach can simplify facility design and improve manufacturing flexibility.

Industry Challenges

Despite strong adoption, several challenges could influence market development. Plastic waste disposal remains an important concern because single-use systems generate significant quantities of polymer-based waste after processing.

Extractables and leachables are another major consideration. Chemical compounds can potentially migrate from polymer materials into drug products under certain processing conditions. This creates additional requirements for material characterization, testing, validation, and regulatory documentation.

Large-scale production also presents limitations. Some high-volume biopharmaceutical manufacturers continue to use stainless-steel systems where reusable infrastructure can be economically attractive at very large production scales. Supply-chain dependencies for specialized polymer films and disposable components can also create operational risks.

Competitive Landscape

The global single-use bioprocessing market includes major biotechnology and life-science technology companies competing through product innovation, capacity expansion, partnerships, and integrated bioprocessing solutions.

Key companies profiled by Grand View Research include Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Avantor, Inc., Eppendorf SE, Corning Incorporated, Boehringer Ingelheim International GmbH, Lonza, and Infors AG.

Companies are focusing on expanded single-use portfolios, customized assemblies, advanced sensors, bioreactors, filtration technologies, and integrated manufacturing platforms. Strategic partnerships with biopharmaceutical manufacturers and CDMOs are also supporting wider deployment of disposable technologies.